Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12610000319077Phase 4Completed
Phase 4, randomised trial of Vaxigrip Junior in influenza (2 arms), sponsored by Australian Research Council. Primary endpoints: Social, economic, and health impact of influenza prevention, Vaccine efficacy and effectiveness against laboratory-proven influenza and influenza-like illness and 1 more. Started Jun 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12610000319077.